CYP19A1 and prostate carcinoma: Overview of the trials registered in the database Clinical Trials (ClinicalTrails.gov) for the use of aromatase, STS and HSD17B1 inhibitors in breast, endometrial, ovarian, prostate cancers and endometriosis.